论文部分内容阅读
前不久,美国波士顿达纳-法伯癌症研究所和德国缅因兹大学的两支科研团队,在英国《自然》杂志上发表了其重要研究成果:针对肿瘤突变定制的个性化疫苗,在恶性黑色素瘤患者治疗中获得巨大成功,超过半数志愿患者的肿瘤消失。这是抗癌疫苗首次在临床试验中取得成功。这个成果是否意味着人们迎来了攻克癌症的曙光?打疫苗等免疫疗法在如今的抗癌战役中,占据什么样的地位呢?
Not long ago, two research teams from the Dana-Farber Cancer Institute in Boston and the Mainez University in Germany published their important research results in Nature, England: a personalized vaccine tailored to tumor mutations, The treatment of melanoma patients has been a great success, more than half of the volunteers in the tumor disappeared. This is the first successful anticancer vaccine in clinical trials. Does this result mean that people usher in the dawn of cancer? Vaccination and other immunotherapy in today’s anti-cancer campaign, occupy what kind of status?